ProMeris Duo

Country: European Union

Language: Lithuanian

Source: EMA (European Medicines Agency)

Patient Information leaflet Patient Information leaflet (PIL)
13-07-2015
Summary of Product characteristics Summary of Product characteristics (SPC)
13-07-2015
Public Assessment Report Public Assessment Report (PAR)
14-07-2015

Active ingredient:

metaflumizone, amitraz

Available from:

Pfizer Limited 

ATC code:

QP53AD51

INN (International Name):

metaflumizone, amitraz

Therapeutic group:

Šunys

Therapeutic area:

Ektoparazitocidinės medžiagos vietiniam vartojimui, įsk. insekticidai

Therapeutic indications:

Blusų (Ctenocephalides canis ir C.) Užkrėtimų gydymui ir prevencijai. felis) ir erkių (Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus, Dermacentor reticulatus ir Dermacentor variabilis), ir gydymo demodicosis (dėl spp Demodex. ) ir utėlėmis (Trichodectes canis) šunims. Veterinarinis vaistas gali būti naudojamas kaip blusų alerginio dermatito (FAD) gydymo strategijos dalis..

Product summary:

Revision: 7

Authorization status:

Panaikintas

Authorization date:

2006-12-19

Patient Information leaflet

                                Medicinal product no longer authorised
B. INFORMACINIS LAPELIS
32
Medicinal product no longer authorised
INFORMACINIS LAPELIS
ProMeris Duo 100,5 mg + 100,5 mg, užlašinamasis tirpalas mažiems
šunims
ProMeris Duo 199,5 mg + 199,5 mg, užlašinamasis tirpalas vidutinio
dydžio šunims
ProMeris Duo 499,5 mg + 499,5 mg, užlašinamasis tirpalas vidutinio
dydžio ir dideliems šunims
ProMeris Duo 799,5 mg + 799,5 mg, užlašinamasis tirpalas dideliems
šunims
ProMeris Duo 999 mg + 999 mg, užlašinamasis tirpalas labai dideliems
šunims
1.
RINKODAROS TEISĖS TURĖTOJO IR UŽ VAISTO SERIJOS IŠLEIDIMĄ EEE
ŠALYSE ATSAKINGO GAMINTOJO, JEI JIE SKIRTINGI, PAVADINIMAS IR
ADRESAS
Rrinkodaros teisės turėtojas
:
Pfizer Limited
Ramsgate Road
Sandwich
Kent CT13 9NJ
Jungtinė Karalystė
Vaisto serijos gamintojas
:
Wyeth Lederle Italia S.p.A.
18, Via Franco Gorgone
95121 Catania
Italy
2.
VETERINARINIO VAISTO PAVADINIMAS
ProMeris Duo 100,5 mg + 100,5 mg, užlašinamasis tirpalas mažiems
šunims
ProMeris Duo 199,5 mg + 199,5 mg, užlašinamasis tirpalas vidutinio
dydžio šunims
ProMeris Duo 499,5 mg + 499,5 mg, užlašinamasis tirpalas vidutinio
dydžio ir dideliems šunims
ProMeris Duo 799,5 mg + 799,5 mg, užlašinamasis tirpalas dideliems
šunims
ProMeris Duo 999 mg + 999 mg, užlašinamasis tirpalas labai dideliems
šunims
3
.
VEIKLIOSIOS IR KITOS MEDŽIAGOS
VEIKLIOSIOS MEDŽIAGOS
1 ml yra 150 mg metaflumizono ir 150 mg amitrazo.
Vienoje ProMeris Duo dozėje (tūbelėje) yra:
PROMERIS DUO, UŽLAŠINAMASIS TIRPALAS
TŪRIS,
ML
METAFLUMIZONAS,
MG
AMITRAZAS,
MG
Mažiems šunims(
≤
5 kg)*
0,67
100,5
100,5
Vidutinio dydžio šunims (5,1–10,0 kg) *
1,33
199,5
199,5
Vidutinio dydžio ir dideliems šunims (10,1–25,0 kg)*
3,33
499,5
499,5
Dideliems šunims (25,1–40,0 kg) *
5,33
799,5
799,5
Labai dideliems šunims (40,1–50,0 kg) *
6,66
999
999
*
DĖL VIETOS STOKOS ANT PAKUOTĖS, ANT LIZDUOČIŲ IR TŪBELIŲ
NAUDOJAMI SUTRUMPINIMAI “S”, “M”,
M/L” IR “XL”, ATITINKANTYS “MAŽO DYDŽIO”, “VIDUTINIO
DYDŽI
                                
                                Read the complete document

Summary of Product characteristics

                                Medicinal product no longer authorised
I PRIEDAS
VETERINARINIO VAISTO APRAŠAS
1
Medicinal product no longer authorised
1.
VETERINARINIO VAISTO PAVADINIMAS
ProMeris Duo 100,5 mg + 100,5 mg, užlašinamasis tirpalas mažiems
šunims
ProMeris Duo 199,5 mg + 199,5 mg, užlašinamasis tirpalas vidutinio
dydžio šunims
ProMeris Duo 499,5 mg + 499,5 mg, užlašinamasis tirpalas vidutinio
dydžio ir dideliems šunims
ProMeris Duo 799,5 mg + 799,5 mg, užlašinamasis tirpalas dideliems
šunims
ProMeris Duo 999 mg + 999 mg, užlašinamasis tirpalas labai dideliems
šunims
2.
KOKYBINĖ IR KIEKYBINĖ SUDĖTIS
VEIKLIOSIOS MEDŽIAGOS
1 ml yra 150 mg metaflumizono ir 150 mg amitrazo.
Vienoje ProMeris Duo dozėje (tūbelėje) yra:
PROMERIS DUO, UŽLAŠINAMASIS TIRPALAS
TŪRIS, ML
METAFLUMIZONAS,
MG
AMITRAZAS,
MG
Mažiems šunims(
≤
5 kg)
0,67
100,5
100,5
Vidutinio dydžio šunims (5,1–10,0 kg)
1,33
199,5
199,5
Vidutinio dydžio ir dideliems šunims (10,1–25,0 kg)
3,33
499,5
499,5
Dideliems šunims (25,1–40,0 kg)
5,33
799,5
799,5
Labai dideliems šunims (40,1–50,0 kg)
6,66
999
999
PAGALBINĖS MEDŽIAGOS
Išsamų pagalbinių medžiagų sąrašą žr. 6.1 p.
3.
VAISTO FORMA
Užlašinamasis tirpalas.
Skaidrus, nuo geltonos iki gintarinės spalvos tirpalas.
4.
KLINIKINIAI DUOMENYS
4.1
PASKIRTIES GYVŪNŲ RŪŠYS
Vyresniems nei 8 sav. amžiaus šunims.
4.2
NAUDOJIMO INDIKACIJOS NURODANT PASKIRTIES GYVŪNŲ RŪŠIS
Šunims gydyti ir profilaktiškai nuo blusų (
_Ctenocephalides canis _
ir
_ C. felis._
) ir erkių (
_Ixodes ricinus_
,
_ _
_I. hexagonus,_
_Rhipicephalus sanquineus_
,
_Dermacentor reticulatus _
ir
_ Dermacentor variabilis_
)
invazijos, taip pat gydyti nuo demodekozės (sukeltos
_Demodex _
spp
_._
) ir utėlių (
_Trichodectes canis_
)
invazijos. Veterinarinis vaistas gali būti naudojamas kaip dalis
gydymo strategijos nuo blusų sukelto
alerginio dermatito.
4.3
KONTRAINDIKACIJOS
Negalima skirti jaunesniems nei 8 sav. amžiaus šuniukams.
Negalima skirti katėms.
Negalima skirti sergantiems ir nusilpusiems šun
                                
                                Read the complete document

Similar products

Active ingredient metaflumizone, amitraz

metaflumizone, amitraz

ATC code QP53AD51

QP53AD51

Marketed by Pfizer Limited 

Pfizer Limited 

INN (International Name) metaflumizone, amitraz

metaflumizone, amitraz

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 13-07-2015
Summary of Product characteristics Summary of Product characteristics Bulgarian 13-07-2015
Public Assessment Report Public Assessment Report Bulgarian 14-07-2015
Patient Information leaflet Patient Information leaflet Spanish 13-07-2015
Summary of Product characteristics Summary of Product characteristics Spanish 13-07-2015
Public Assessment Report Public Assessment Report Spanish 14-07-2015
Patient Information leaflet Patient Information leaflet Czech 13-07-2015
Summary of Product characteristics Summary of Product characteristics Czech 13-07-2015
Public Assessment Report Public Assessment Report Czech 14-07-2015
Patient Information leaflet Patient Information leaflet Danish 13-07-2015
Summary of Product characteristics Summary of Product characteristics Danish 13-07-2015
Public Assessment Report Public Assessment Report Danish 14-07-2015
Patient Information leaflet Patient Information leaflet German 13-07-2015
Summary of Product characteristics Summary of Product characteristics German 13-07-2015
Public Assessment Report Public Assessment Report German 14-07-2015
Patient Information leaflet Patient Information leaflet Estonian 13-07-2015
Summary of Product characteristics Summary of Product characteristics Estonian 13-07-2015
Public Assessment Report Public Assessment Report Estonian 14-07-2015
Patient Information leaflet Patient Information leaflet Greek 13-07-2015
Summary of Product characteristics Summary of Product characteristics Greek 13-07-2015
Public Assessment Report Public Assessment Report Greek 14-07-2015
Patient Information leaflet Patient Information leaflet English 13-07-2015
Summary of Product characteristics Summary of Product characteristics English 13-07-2015
Public Assessment Report Public Assessment Report English 14-07-2015
Patient Information leaflet Patient Information leaflet French 13-07-2015
Summary of Product characteristics Summary of Product characteristics French 13-07-2015
Public Assessment Report Public Assessment Report French 14-07-2015
Patient Information leaflet Patient Information leaflet Italian 13-07-2015
Summary of Product characteristics Summary of Product characteristics Italian 13-07-2015
Public Assessment Report Public Assessment Report Italian 14-07-2015
Patient Information leaflet Patient Information leaflet Latvian 13-07-2015
Summary of Product characteristics Summary of Product characteristics Latvian 13-07-2015
Public Assessment Report Public Assessment Report Latvian 14-07-2015
Patient Information leaflet Patient Information leaflet Hungarian 13-07-2015
Summary of Product characteristics Summary of Product characteristics Hungarian 13-07-2015
Public Assessment Report Public Assessment Report Hungarian 14-07-2015
Patient Information leaflet Patient Information leaflet Maltese 13-07-2015
Summary of Product characteristics Summary of Product characteristics Maltese 13-07-2015
Public Assessment Report Public Assessment Report Maltese 14-07-2015
Patient Information leaflet Patient Information leaflet Dutch 13-07-2015
Summary of Product characteristics Summary of Product characteristics Dutch 13-07-2015
Public Assessment Report Public Assessment Report Dutch 14-07-2015
Patient Information leaflet Patient Information leaflet Polish 13-07-2015
Summary of Product characteristics Summary of Product characteristics Polish 13-07-2015
Public Assessment Report Public Assessment Report Polish 14-07-2015
Patient Information leaflet Patient Information leaflet Portuguese 13-07-2015
Summary of Product characteristics Summary of Product characteristics Portuguese 13-07-2015
Public Assessment Report Public Assessment Report Portuguese 14-07-2015
Patient Information leaflet Patient Information leaflet Romanian 13-07-2015
Summary of Product characteristics Summary of Product characteristics Romanian 13-07-2015
Public Assessment Report Public Assessment Report Romanian 14-07-2015
Patient Information leaflet Patient Information leaflet Slovak 13-07-2015
Summary of Product characteristics Summary of Product characteristics Slovak 13-07-2015
Public Assessment Report Public Assessment Report Slovak 14-07-2015
Patient Information leaflet Patient Information leaflet Slovenian 13-07-2015
Summary of Product characteristics Summary of Product characteristics Slovenian 13-07-2015
Public Assessment Report Public Assessment Report Slovenian 14-07-2015
Patient Information leaflet Patient Information leaflet Finnish 13-07-2015
Summary of Product characteristics Summary of Product characteristics Finnish 13-07-2015
Public Assessment Report Public Assessment Report Finnish 14-07-2015
Patient Information leaflet Patient Information leaflet Swedish 13-07-2015
Summary of Product characteristics Summary of Product characteristics Swedish 13-07-2015
Public Assessment Report Public Assessment Report Swedish 14-07-2015
Patient Information leaflet Patient Information leaflet Norwegian 13-07-2015
Summary of Product characteristics Summary of Product characteristics Norwegian 13-07-2015
Patient Information leaflet Patient Information leaflet Icelandic 13-07-2015
Summary of Product characteristics Summary of Product characteristics Icelandic 13-07-2015

Search alerts related to this product

Alerts ProMeris Duo metaflumizone, amitraz

ProMeris Duo metaflumizone, amitraz

View documents history

Documents history Documents history

ProMeris Duo